EUVIMEDUpptäck EUVIMED
Crossref

Cinnamaldehyde Regulates the EMT Process and Drug Resistance of Gastric Cancer Through FSTL3 ‐Mediated Cytoskeletal Remodeling

Shuhong Zeng iD, Yi Yin, Ying Zhang, Zuopeng Xiao, Jiepin Li, Yuanjie Liu, Jinyong Zhou, Xi Zou iD, Weixing Shen

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70292 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Shuhong Zeng and 8 co-authors. Institution: Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China. Major MEDLINE topics: Epithelial-Mesenchymal Transition, Acrolein, Stomach Neoplasms, Follistatin-Related Proteins. Cited 2 times so far (Crossref); 42 references. Funded by: National Natural Science Foundation of China, Young Elite Scientists Sponsorship Program by Suzhou Association for Science and Technology, Jiangsu Provincial Medical Key Laboratory.

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Cinnamaldehyde (CA) is known to possess anti‐tumor properties, such as inhibiting proliferation and migration. However, the specific role and molecular mechanism of CA in gastric cancer (GC) remain unclear. This study aimed to elucidate its effects on GC cell proliferation, migration, epithelial‐mesenchymal transition (EMT), and drug resistance, and to explore the potential involvement of follistatin‐like 3 (FSTL3) in these processes. The study employed both in vitro and in vivo approaches. In vitro, GC cells were treated with CA to assess its impact on cell proliferation, migration, and EMT. The expression and role of FSTL3 were analyzed. In vivo, the GC xenograft model and intrasplenic injection liver metastasis model were used to confirm the antitumor effects and the ability to resist metastasis of CA. CA treatment significantly downregulated the expression of FSTL3 in GC cells and altered cytoskeleton expression and distribution. Functionally, CA effectively inhibited GC cell proliferation and migration. These antitumor effects were crucially mediated through FSTL3. The in vivo experiments consistently demonstrated that CA suppressed GC tumor growth, invasion, and metastasis by modulating the expression of EMT‐related proteins and TGF‐β/SMAD signaling via FSTL3. This study demonstrates that the antitumor effects of CA on GC are primarily mediated through FSTL3 downregulation. These findings implicate FSTL3 as a promising therapeutic target for treating GC and overcoming drug resistance.

Subjects

MeSH terms (MEDLINE)

Epithelial-Mesenchymal TransitionAcroleinStomach NeoplasmsFollistatin-Related ProteinsDrug Resistance, NeoplasmCytoskeletonAnimalsHumansCell ProliferationCell MovementCell Line, TumorMiceSignal TransductionMice, NudeTransforming Growth Factor betaMice, Inbred BALB CMaleAntineoplastic Agents, PhytogenicXenograft Model Antitumor Assays

Author keywords

FSTL3cinnamaldehydecytoskeletondrug resistanceepithelial‐mesenchymal transitiongastric cancer

Substances

AcroleinFollistatin-Related ProteinscinnamaldehydeTransforming Growth Factor betaAntineoplastic Agents, Phytogenic

Authors and institutions

  • Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
  • No.1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
  • Department of Chinese Medicine, Affiliated Changshu Hospital of Nantong University, Changshu No. 2 People's Hospital, Changshu, China.
  • Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, Nanjing, China.
  • Department of Chinese Medicine, Peixian People's Hospital, Xuzhou, China.
  • Department of Oncology, Liyang Branch of Jiangsu Provincial Hospital of Chinese Medicine, Liyang, China.

ORCID profiles: Shuhong Zeng, Xi Zou

Funding

  • National Natural Science Foundation of China
  • Young Elite Scientists Sponsorship Program by Suzhou Association for Science and Technology
  • Jiangsu Provincial Medical Key Laboratory
  • Suzhou Science and Technology Research Program (Medical Innovation)
  • High-level Talents Project of "Talent Peaks" in Jiangsu Province Hospital of Chinese Medicine
  • "Gusu Yixing" Young Elite Scientists Sponsorship Program by Suzhou Medical Association
  • Young Elite Scientists Sponsorship Program by Jiangsu Provincial Association for Science and Technology
  • Changshu Science and Technology Development Plan (Kuncheng Talent Program)

Cite

APA

Zeng, S., Yin, Y., Zhang, Y., Xiao, Z., Li, J., Liu, Y., Zhou, J., Zou, X., & Shen, W. (2026). Cinnamaldehyde Regulates the EMT Process and Drug Resistance of Gastric Cancer Through FSTL3 ‐Mediated Cytoskeletal Remodeling. Phytotherapy Research. https://doi.org/10.1002/ptr.70292

Vancouver

Zeng S, Yin Y, Zhang Y, Xiao Z, Li J, Liu Y, et al. Cinnamaldehyde Regulates the EMT Process and Drug Resistance of Gastric Cancer Through FSTL3 ‐Mediated Cytoskeletal Remodeling. Phytotherapy Research. 2026. doi:10.1002/ptr.70292

BibTeX
@article{Zeng2026,
  author = {Zeng, Shuhong and Yin, Yi and Zhang, Ying and Xiao, Zuopeng and Li, Jiepin and Liu, Yuanjie and Zhou, Jinyong and Zou, Xi and Shen, Weixing},
  title = {Cinnamaldehyde Regulates the EMT Process and Drug Resistance of Gastric Cancer Through FSTL3 ‐Mediated Cytoskeletal Remodeling},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70292}
}
Start for free →